Redx Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Redx Pharma has a total shareholder equity of £3.4M and total debt of £15.7M, which brings its debt-to-equity ratio to 468.9%. Its total assets and total liabilities are £25.6M and £22.3M respectively.
Key information
468.9%
Debt to equity ratio
UK£15.73m
Debt
| Interest coverage ratio | n/a |
| Cash | UK£18.09m |
| Equity | UK£3.36m |
| Total liabilities | UK£22.28m |
| Total assets | UK£25.64m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0RX's short term assets (£23.3M) exceed its short term liabilities (£21.0M).
Long Term Liabilities: 0RX's short term assets (£23.3M) exceed its long term liabilities (£1.3M).
Debt to Equity History and Analysis
Debt Level: 0RX has more cash than its total debt.
Reducing Debt: 0RX's debt to equity ratio has increased from 0% to 468.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0RX has sufficient cash runway for 6 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 0RX is forecast to have sufficient cash runway for 5 months based on free cash flow estimates, but has since raised additional capital.